These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 10773607)

  • 1. Hyperparathyroidism and anemia in renal failure.
    Gallieni M; Corsi C; Brancaccio D
    Am J Nephrol; 2000; 20(2):89-96. PubMed ID: 10773607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging Association Between Parathyroid Hormone and Anemia in Hemodialysis Patients.
    Tanaka M; Komaba H; Fukagawa M
    Ther Apher Dial; 2018 Jun; 22(3):242-245. PubMed ID: 29767854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Secondary hyperparathyroidism and tertiary hyperparathyroidism chronic renal failure, uremia].
    Morio K; Koide K
    Nihon Rinsho; 1995 Apr; 53(4):958-64. PubMed ID: 7752492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secondary hyperparathyroidism as cause of resistance to treatment with erythropoietin: effect of parathyroidectomy.
    Goicoechea M; Gomez-Campdera F; Polo JR; Tejedor A; Ruiz MA; Vazquez I; Verde E; Valderrabano F
    Clin Nephrol; 1996 Jun; 45(6):420-1. PubMed ID: 8793241
    [No Abstract]   [Full Text] [Related]  

  • 5. Improved anemia and reduced erythropoietin need by medical or surgical intervention of secondary hyperparathyroidism in hemodialysis patients.
    Lin CL; Hung CC; Yang CT; Huang CC
    Ren Fail; 2004 May; 26(3):289-95. PubMed ID: 15354979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperparathyroidism and anemia in uremic subjects: a combined therapeutic approach.
    Brancaccio D; Cozzolino M; Gallieni M
    J Am Soc Nephrol; 2004 Jan; 15 Suppl 1():S21-4. PubMed ID: 14684666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secondary hyperparathyroidism in children with chronic renal failure: pathogenesis and treatment.
    Sanchez CP
    Paediatr Drugs; 2003; 5(11):763-76. PubMed ID: 14580225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Renal osteodystrophy (2): its treatment in renal insufficiency before dialysis].
    Hottelart C; Bako G; Oprisiu R; Georgita A; Presne C; Sarraj A; Morinière P; el Esper N; Fournier A
    Nephrologie; 2000; 21(6):275-82. PubMed ID: 11117106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent changes in therapeutic approaches and association with outcomes among patients with secondary hyperparathyroidism on chronic hemodialysis: the DOPPS study.
    Tentori F; Wang M; Bieber BA; Karaboyas A; Li Y; Jacobson SH; Andreucci VE; Fukagawa M; Frimat L; Mendelssohn DC; Port FK; Pisoni RL; Robinson BM
    Clin J Am Soc Nephrol; 2015 Jan; 10(1):98-109. PubMed ID: 25516917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current advances in the therapy of secondary hyperparathyroidism and osteitis fibrosa.
    Llach F; Nikakhtar B
    Miner Electrolyte Metab; 1991; 17(4):250-5. PubMed ID: 1813787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improvement of anemia after parathyroidectomy in Chinese patients with renal failure undergoing long-term dialysis.
    Chow TL; Chan TT; Ho YW; Lam SH
    Arch Surg; 2007 Jul; 142(7):644-8. PubMed ID: 17638802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of surgical parathyroidectomy for secondary hyperparathyroidism in renal dialysis patients in Qatar.
    Rashed A; Fahmi M; ElSayed M; Aboud O; Asim M
    Transplant Proc; 2004; 36(6):1815-7. PubMed ID: 15350484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A transitory polycytaemia after parathyroidectomy for secondary hyperparathyroidism--a literature survey and a case study.
    Krivoshiev SG; Vazelov ES; Kovatcheva RD; Kanev NA; Borissova AM
    Folia Med (Plovdiv); 2004; 46(1):45-9. PubMed ID: 15362814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of secondary hyperparathyroidism in erythropoietin resistance of chronic renal failure patients.
    Drüeke TB; Eckardt KU
    Nephrol Dial Transplant; 2002; 17 Suppl 5():28-31. PubMed ID: 12091604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes of secondary hyperparathyroidism in chronic kidney disease and the direct costs of treatment.
    Joy MS; Karagiannis PC; Peyerl FW
    J Manag Care Pharm; 2007 Jun; 13(5):397-411. PubMed ID: 17605511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medical and surgical treatment for secondary and tertiary hyperparathyroidism.
    Schlosser K; Zielke A; Rothmund M
    Scand J Surg; 2004; 93(4):288-97. PubMed ID: 15658670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secondary hyperparathyroidism in chronic renal failure.
    Malmaeus J
    Scand J Urol Nephrol Suppl; 1983; 70():1-63. PubMed ID: 6351238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anemia and secondary hyperparathyroidism.
    Zingraff J; Drüeke T; Marie P; Man NK; Jungers P; Bordier P
    Arch Intern Med; 1978 Nov; 138(11):1650-2. PubMed ID: 718313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of serum parathyroid hormone and bone marrow fibrosis on the response to erythropoietin in uremia.
    Rao DS; Shih MS; Mohini R
    N Engl J Med; 1993 Jan; 328(3):171-5. PubMed ID: 8417383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.